Skip to content

Author

Chang-Jiang Du

We have 1 of 1 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Radiotherapy for overcoming immune checkpoint inhibitor resistance in esophageal squamous cell carcinoma

Clinical evidence for radiotherapy-immunotherapy combinations in ICI-resistant ESCC is evaluated, the distinct roles of stereotactic body radiotherapy (SBRT) and low-dose radiotherapy (LDRT), and a “barrier-exhaustion score” is proposed as a hypothetical tool to guide individualized treatment are evaluated.

Chang-Jiang Du, Yuan-Fei Li · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.